Moreover, in a separate study[23], Tagawa et al. identified 3q23-3q28 (31%), 6q22.31-q24.1 (44%) and 9p21.3 (50%) in high frequency for CD5+ DLBCL. This evidence concerns the gene CD5 and diffuse large B-cell lymphoma.